1.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 21 Sponsor: Other Protocol IDs: PK01/16/08, NCT00808184
|
|
2.
|
Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: DERMATUX, NCT01315990
|
|
3.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2012-03, NCT01564810
|
|
4.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ML25753, NCT01588990
|
|
5.
|
Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 21 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 0869-225, MK-0869-225, NCT01636947
|
|
6.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: Haema CBF SCLC UK/AS 01, NCT00168896
|
|
7.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 08-PIR-03, NCT00856375
|
|
8.
|
Phase: Phase III Type: Treatment Status: Active Age: 75 and under Sponsor: Other Protocol IDs: FFCD 2000 – 05, CET 815, NCT00126256
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: AERO-R98, NCT00189657
|
|
10.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 50 Sponsor: NCI Protocol IDs: COG-ARST0531, NCT00354835, ARST0531
|
|
11.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CTRU-PICCOLO-MO-05-7289, EUDRACT-2005-003492-20, CTAAC-CTRU-PICCOLO-MO-05-7289, AMGEN-CTRU-PICCOLO-MO-05-7289, EU-20647, NCT00389870
|
|
12.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: FIRE-3, NCT00433927
|
|
13.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: CDR0000598567, GONO-BEBYP-ASL607LIOM03, GONO-AIFA - FARM5C4FB4, EUDRACT:2007-002886-11, GONO– ASL607LIOM03, EU-20860, NCT00720512
|
|
14.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: CDR0000598582, GONO-TRIBE, ASL608LIOM04, EUDRACT:2008-001537-10, TRIBE, EU-20859, NCT00719797
|
|
15.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: SICOG-0803, SICOG 0803, MARTHA, EudraCT-2008-004890-17, NCT00797485
|
|
16.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20080259, NCT00911170
|
|
17.
|
Phase: Phase III Type: Tissue collection/Repository, Treatment Status: Active Age: 21 and under Sponsor: NCI Protocol IDs: COG-AHEP0731, AHEP0731, NCT00980460
|
|
18.
|
Phase: Phase III Type: Tissue collection/Repository, Treatment Status: Active Age: No age specified Sponsor: Other Protocol IDs: CPT-SIOP-2009, NCT01014767
|
|
19.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2007-006254-26, NCT01030042
|
|
20.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13856, I4T-MC-JVBB, CP12-0920, 2010-021037-32, CTRI/2011/07/001900, NCT01183780
|
|
21.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: KCSG-ST10-01, NCT01224652
|
|
22.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 19 Sponsor: Other Protocol IDs: 2009-11-017, NCT01238094
|
|
23.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: ML22011, NCT01249638
|
|
24.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ACO-002, NCT01290783
|
|
25.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: CPP-450, 2010-019140-39, NCT01317433
|